TGF-β receptor controls B cell responsiveness and induction of IgA in vivo

Immunity

Volumn 13, Issue 4, 2000, Pages 443-451

  Cazac, Balthazar B ^a   Roes, Jürgen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL HYPERPLASIA; CELL SUBPOPULATION; CELL TYPE; CONTROLLED STUDY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; MOUSE; MUTAGENESIS; NONHUMAN; PERITONEUM CELL; PEYER PATCH; PRIORITY JOURNAL;

EID: 0033697670     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)00044-3     Document Type: Article

References (66)

1. Effect of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes
2. IgA deficiency
3. Surface phenotype of Peyer's patch germinal center bells: Implications for the role of germinal centers in B cell differentiation
4. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
5. Genomic sequencing
6. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes
7. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice
8. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated
9. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest
10. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
11. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow
12. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice
13. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
14. Most peripheral B cells in mice are ligand selected
15. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-IoxP-mediated gene targeting
16. Positive selection of natural autoreactive B cells
17. Positive versus negative signaling by lymphocyte antigen receptors
18. TGF-beta signalling from cell membrane to nucleus through SMAD proteins
19. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-beta, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis
20. Origin of murine B cell lineages
21. Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-beta
22. Generation and analysis of interleukin-4 deficient mice
23. Interleukin-10-deficient mice develop chronic enterocolitis
24. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
25. Simplified mammalian DNA isolation procedure
26. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development
27. The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1
28. Regulation of immune responses by TGF-beta
29. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression
30. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes
31. Insights into the control of immunoglobulin class switch recombination from analysis of targeted mice
32. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria
33. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
34. Transcriptional control by the TGF-beta/Smad signaling system
35. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering
36. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
37. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
38. Antigen sampling across epithelial barriers and induction of mucosal immune responses
39. CD22 is a negative regulator of B-cell receptor signalling
40. Hyperresponsive B cells in CD22-deficient mice
41. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis
42. CD22 regulates thymus-independent responses and the lifespan of B cells
43. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras
44. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB (low) CD4+ T cells
45. Clonal selection and learning in the antibody system
46. Conditional gene targeting
47. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
48. B lymphocyte-specific, Cre-mediated mutagenesis in mice
49. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells
50. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice
51. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1
52. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection
53. CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter
54. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
55. X-linked agammaglobulinemia and other immunoglobulin deficiencies
56. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro
57. IgA production in MHC class II-deficient mice is primarily a function of B-1a cells
58. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity
59. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production
60. The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII)
61. T cell-dependent antibody production by Ly-1 B cells
62. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G
63. Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice
64. CD43 (S7) expression identifies peripheral B cell subsets
65. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
66. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: Evidence for TGF-beta but not IL-10-dependent direct S mu→S alpha and sequential S mu→S gamma, S gamma→S alpha DNA recombination